365 related articles for article (PubMed ID: 28872614)
1. Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia.
Bongiovanni D; Saccomani V; Piovan E
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28872614
[TBL] [Abstract][Full Text] [Related]
2. T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies.
Cordo' V; van der Zwet JCG; Canté-Barrett K; Pieters R; Meijerink JPP
Blood Cancer Discov; 2021 Jan; 2(1):19-31. PubMed ID: 34661151
[TBL] [Abstract][Full Text] [Related]
3. HSF1-Mediated Control of Cellular Energy Metabolism and mTORC1 Activation Drive Acute T-Cell Lymphoblastic Leukemia Progression.
Eroglu B; Pang J; Jin X; Xi C; Moskophidis D; Mivechi NF
Mol Cancer Res; 2020 Mar; 18(3):463-476. PubMed ID: 31744878
[TBL] [Abstract][Full Text] [Related]
4. Thymus-Brain Connections in T-Cell Acute Lymphoblastic Leukemia.
Mendes-da-Cruz DA; Belorio EP; Cotta-de-Almeida V
Neuroimmunomodulation; 2024; 31(1):51-61. PubMed ID: 38272012
[TBL] [Abstract][Full Text] [Related]
5. The genetics and molecular biology of T-ALL.
Girardi T; Vicente C; Cools J; De Keersmaecker K
Blood; 2017 Mar; 129(9):1113-1123. PubMed ID: 28115373
[TBL] [Abstract][Full Text] [Related]
6. Concepts in B cell acute lymphoblastic leukemia pathogenesis.
Garcia C; Miller-Awe MD; Witkowski MT
J Leukoc Biol; 2024 Jun; 116(1):18-32. PubMed ID: 38243586
[TBL] [Abstract][Full Text] [Related]
7. T-ALL in CNS-3 status needs improvement.
Ribera JM
Blood; 2023 Apr; 141(15):1779-1780. PubMed ID: 37052942
[No Abstract] [Full Text] [Related]
8. Potency and efficacy of pharmacological PIP4K2 inhibitors in acute lymphoblastic leukemia.
Lima K; Nogueira FL; Cipelli M; Carvalho MFL; Pereira-Martins DA; da Silva WF; Cavaglieri RC; Nardinelli L; Leal AM; Velloso EDRP; Bendit I; Câmara NOS; Schuringa JJ; Machado-Neto JA; Rego EM
Eur J Pharmacol; 2024 Jun; 977():176723. PubMed ID: 38851560
[TBL] [Abstract][Full Text] [Related]
9. Leukemia-Initiating Cells in T-Cell Acute Lymphoblastic Leukemia.
Tan SH; Bertulfo FC; Sanda T
Front Oncol; 2017; 7():218. PubMed ID: 29034206
[TBL] [Abstract][Full Text] [Related]
10. The suprachiasmatic nucleus: a 25-year retrospective.
Weaver DR
J Biol Rhythms; 1998 Apr; 13(2):100-12. PubMed ID: 9554572
[TBL] [Abstract][Full Text] [Related]
11. Cost-effective screening of DNMT3A coding sequence identifies somatic mutation in pediatric T-cell acute lymphoblastic leukemia.
Szarzyńska-Zawadzka B; Kosmalska M; Sędek Ł; Sonsala A; Twardoch M; Kowalczyk JR; Szczepański T; Witt M; Dawidowska M
Eur J Haematol; 2017 Dec; 99(6):514-519. PubMed ID: 28905428
[TBL] [Abstract][Full Text] [Related]
12. In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL.
Laukkanen S; Grönroos T; Pölönen P; Kuusanmäki H; Mehtonen J; Cloos J; Ossenkoppele G; Gjertsen B; Øystein B; Heckman C; Heinäniemi M; Kontro M; Lohi O
Blood Cancer J; 2017 Sep; 7(9):e604. PubMed ID: 28885610
[No Abstract] [Full Text] [Related]
13. Defining the molecular basis of oncogenic cooperation between TAL1 expression and Pten deletion in T-ALL using a novel pro-T-cell model system.
Bornschein S; Demeyer S; Stirparo R; Gielen O; Vicente C; Geerdens E; Ghesquière B; Aerts S; Cools J; de Bock CE
Leukemia; 2018 Apr; 32(4):941-951. PubMed ID: 29151585
[TBL] [Abstract][Full Text] [Related]
14. T-cell prolymphocytic leukemia and tuberculosis: a puzzling association.
Cervera P; Gilhot A; Marzac C; Féger F; Tang R; Jaff N; Coppo P
Clin Case Rep; 2017 Sep; 5(9):1536-1541. PubMed ID: 28878921
[TBL] [Abstract][Full Text] [Related]
15. Signaling pathways in cardiac myocyte hypertrophy.
Hefti MA; Harder BA; Eppenberger HM; Schaub MC
J Mol Cell Cardiol; 1997 Nov; 29(11):2873-92. PubMed ID: 9405163
[TBL] [Abstract][Full Text] [Related]
16. Relapsed T Cell ALL: Current Approaches and New Directions.
McMahon CM; Luger SM
Curr Hematol Malig Rep; 2019 Apr; 14(2):83-93. PubMed ID: 30880359
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in the Biology and Treatment of T Cell Acute Lymphoblastic Leukemia.
Hefazi M; Litzow MR
Curr Hematol Malig Rep; 2018 Aug; 13(4):265-274. PubMed ID: 29948644
[TBL] [Abstract][Full Text] [Related]
18. PLK1 as a cooperating partner for BCL2-mediated antiapoptotic program in leukemia.
Shah K; Nasimian A; Ahmed M; Al Ashiri L; Denison L; Sime W; Bendak K; Kolosenko I; Siino V; Levander F; Palm-Apergi C; Massoumi R; Lock RB; Kazi JU
Blood Cancer J; 2023 Sep; 13(1):139. PubMed ID: 37679323
[TBL] [Abstract][Full Text] [Related]
19. Venetoclax-Resistant T-ALL Cells Display Distinct Cancer Stem Cell Signatures and Enrichment of Cytokine Signaling.
Shah K; Al Ashiri L; Nasimian A; Ahmed M; Kazi JU
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902436
[TBL] [Abstract][Full Text] [Related]
20. Understanding the Roles of the Hedgehog Signaling Pathway during T-Cell Lymphopoiesis and in T-Cell Acute Lymphoblastic Leukemia (T-ALL).
Martelli AM; Paganelli F; Truocchio S; Palumbo C; Chiarini F; McCubrey JA
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
